Accuracy of Corneal Astigmatism in Different Region Modes
Condition(s) studied
Investigational drug(s) / intervention(s)
patients with corneal astigmatism: The total corneal astigmatism, anterior chamber depth, will be measured by a Scheimpflug tomographer. Pupil size will be measured by itrace device and MONCV3 device. Residual astigmatism will be tested by subjective refraction.
Study summary
To analyze the difference between measured total corneal astigmatism and actual corneal astigmatism under different region modes and optimize the region setting.
Eligibility
Primary outcome measure(s)
- Vectorial difference — ≥1 month after surgery
The vectorial difference between measured corneal astigmatism (under multiple different region mode settings) and actual corneal astigmatism. - pupil size — ≥1 month after surgery
pupil size of patients in a bright environment measured by itrace device and MONCV3 device - pupil size 2 — ≥1 month after surgery
pupil size of patients measured by Pentacam HR device - residual astigmatism — ≥1 month after surgery
residual astigmatism tested by subjective refraction - total corneal astigmatism — ≥1 month after surgery
Total corneal astigmatism measured by a scheimpflug tomographer under different region mode settings. - Anterior chamber depth — ≥1 month after surgery
The distance between corneal apex and anterior surface of IOL measured by a scheimpflug tomographer - actual corneal astigmatism — ≥1 month after surgery
actual corneal astigmatism is derived from residual astigmatism at corneal plane and cylindrical power of IOL at corneal plane through Holladay 2 formula.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Eye Hispital of Wenzhou Medical University | Wenzhou | Zhejiang | Recruiting |
More Wenzhou Medical University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03299530 on ClinicalTrials.gov ↗ ← All trials in China